Seqirus

WIPO WIPO 2015

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke Seqirus wurde als Bildmarke am 01.07.2015 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Linien, Bänder #Briefe, die eine besondere Form des Schreibens darstellen #Farben #Gekrümmte Linien oder Bänder (außer A 26.11.13) #Zwei vorherrschende Farben

Markendetails Letztes Update: 26. September 2018

Markenform Bildmarke
Aktenzeichen 1271876
Länder Schweiz China Europäische Gemeinschaft Indien Japan Südkorea Mexiko Norwegen Singapur
Basismarke AU Nr. 1701396, 18. Juni 2015
Anmeldedatum 01. Juli 2015
Ablaufdatum 01. Juli 2025

Markeninhaber

Point, 29 Market Street
Maidenhead, Berkshire SL6 8AA
GB

Markenvertreter

Level 15, 1 Nicholson Street AU

Waren und Dienstleistungen

01 Chemical and biological reagents in this class; cell cultures and media in this class; chemical test kits for scientific and laboratory use in this class; chemical preparations for scientific and/or industrial purposes; diagnostic and testing agents in this class; chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells
05 Pharmaceutical preparations and substances in this class; vaccines; blood products in this class; products derived from blood and products derived from recombinant dna technology; serums; antibodies; pharmaceutical test kits in this class, being for diagnostic medical purposes; influenza vaccines; adjuvants and antigens; pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders; blood products in this class, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant dna technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits in the class, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, rhd reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or igg subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes
44 Medical services; medical information services; health care services; health care information services; patient support services in the nature of providing health care and medical care information services, patient support programs and patient assistance programs for providing low cost drugs; providing medical information concerning blood products; providing medical information concerning vaccines, anti-venoms and immunohaematology products, namely, diagnostic reagents; patient support services, namely, providing medical information, including patient medical information via an Internet-based database, where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
15. Mai 2017 2017/20 Gaz IN Ablehnung
10. Mai 2017 2017/19 Gaz MX Ablehnung
03. März 2017 2018/39 Gaz CN Ablehnung
17. Februar 2017 2017/17 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
17. November 2016 2017/2 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
04. November 2016 2017/23 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
13. Oktober 2016 2016/43 Gaz CH Ablehnung
07. Oktober 2016 2016/41 Gaz NO RAW: Rule 18ter(2)(i) GP following a provisional refusal
08. September 2016 2016/37 Gaz EM Ablehnung
07. Juli 2016 2016/30 Gaz JP Ablehnung
27. Mai 2016 2016/23 Gaz KR Ablehnung
28. April 2016 2016/19 Gaz NO Ablehnung
27. April 2016 2016/21 Gaz SG Ablehnung
28. Oktober 2015 2015/50 Gaz AU Korrektur
01. Juli 2015 2015/43 Gaz AU Eintragung

ID: 141271876